Document

Free shipping on orders over $150

Free shipping on orders over $150

Free shipping on orders over $150

Free shipping on orders over $150

Free shipping on orders over $150

Free shipping on orders over $150

Free shipping on orders over $150

Free shipping on orders over $150

Free shipping on orders over $150

Free shipping on orders over $150

Free shipping on orders over $150

Free shipping on orders over $150

Free shipping on orders over $150

Free shipping on orders over $150

Cjc-1295

Cjc-1295



Price range: $60.00 through $95.00

CJC-1295 is a synthetic analog of growth hormone–releasing hormone (GHRH) engineered to enhance stability and receptor interaction in experimental models. It is studied for its binding to GHRH receptors and modulation of somatotropic axis signaling pathways. Preclinical research utilizes CJC-1295 to investigate receptor activation kinetics, intracellular signaling cascades, and peptide-mediated regulation of growth hormone pathways under controlled laboratory conditions.

For research use only. Not for human consumption.

References:
Teichman SL et al., J Clin Endocrinol Metab, 2006
Vance ML et al., Metabolism, 1985
Bowers CY et al., Endocrinology, 1980

Available Options

Description

CJC-1295 is a synthetic peptide analog of GHRH widely studied in laboratory research focused on growth hormone regulatory signaling and endocrine pathway modulation. It serves as a research tool for examining somatotropic axis activation mechanisms.

Biochemical Characteristics

CJC-1295 is structurally derived from endogenous GHRH and designed to enhance peptide stability and receptor affinity in experimental systems. Its molecular structure supports controlled evaluation of receptor-binding dynamics and downstream intracellular signaling activation.

Research Applications

CJC-1295 is utilized in research models investigating growth hormone signaling pathways, receptor interaction kinetics, peptide stability, and endocrine feedback regulation under laboratory conditions.

Pathway / Mechanistic Context

Mechanistic research focuses on CJC-1295 interaction with GHRH receptors and activation of downstream signaling cascades associated with growth hormone synthesis and release within the somatotropic axis.

Preclinical Research Summary

Preclinical investigations have evaluated CJC-1295 in in vitro and experimental models to better understand receptor-mediated endocrine signaling and growth hormone pathway modulation.

Form & Analytical Testing

CJC-1295 is supplied as a lyophilized peptide and undergoes analytical verification, including HPLC testing, to confirm identity, purity, and composition consistency for laboratory research use.

RUO Disclaimer

This product is intended strictly for research and laboratory use only. It is not approved for human consumption, medical treatment, veterinary use, cosmetic application, or diagnostic purposes. Handling should be performed only by qualified professionals trained in proper laboratory procedures.

Additional information

Strength

5 mg, 10 mg

Reviews

There are no reviews yet.

Be the first to review “Cjc-1295”

Your email address will not be published. Required fields are marked *